Publicaciones en las que colabora con MARÍA ISABEL ZAMALLOA JAUREGUI (21)

2022

  1. Attachment anxiety as mediator of the relationship between childhood trauma and personality dysfunction in borderline personality disorder

    Clinical Psychology and Psychotherapy, Vol. 29, Núm. 2, pp. 501-511

2021

  1. Factors influencing the effect of aripiprazole on prolactin levels in patients treated with risperidone or paliperidone. Sex seems to matter

    Schizophrenia Research, Vol. 228, pp. 382-384

2020

  1. Genetic modulation of facial emotion recognition in borderline personality disorder

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 99

2019

  1. GAD1 gene polymorphisms are associated with bipolar I disorder and with blood homovanillic acid levels but not with plasma GABA levels

    Neurochemistry International, Vol. 124, pp. 152-161

2016

  1. COMT haplotypes, catecholamine metabolites in plasma and clinical response in schizophrenic and bipolar patients

    Pharmacogenomics, Vol. 17, Núm. 8, pp. 837-851

2013

  1. The Influence of the Val158Met Catechol-O-Methyltransferase Polymorphism on the Personality Traits of Bipolar Patients

    PLoS ONE, Vol. 8, Núm. 4

2010

  1. Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients

    Neurochemistry International, Vol. 56, Núm. 6-7, pp. 774-779

  2. Factores biológicos en el diagnostico diferencial de los trastornos bipolares

    Avances en salud mental relacional, Vol. 6, Núm. 3

  3. GABA and homovanillic acid in the plasma of schizophrenic and bipolar i patients

    Neurochemical Research, Vol. 35, Núm. 2, pp. 247-253

2009

  1. Diagnóstico "adyuvantivus" y terapia electroconvulsiva: a propósito de un caso

    Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica, Vol. 16, Núm. 3, pp. 131-133

  2. Efecto paradójico del tratamiento con aripiprazol en un paciente bipolar: de la psicofarmacología a la psicopatología

    Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica, Vol. 16, Núm. 2, pp. 94-96

2008

  1. Biological correlates of the congruence and incongruence of psychotic symptoms in patients with type 1 bipolar disorder

    Neuropsychobiology, Vol. 58, Núm. 3-4, pp. 111-117

  2. Marcadores biológicos en el diagnóstico diferencial de los trastornos bipolares

    Norte de Salud Mental, Vol. 7, Núm. 30, pp. 10-14

2007

  1. Inter- and intra-individual variability in the levels of plasma homovanillic acid in schizophrenic patients

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 31, Núm. 3, pp. 713-719

2006

  1. Influence of the catechol-O-methyltransferase Val108/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder-A preliminary report

    Journal of Affective Disorders, Vol. 92, Núm. 2-3, pp. 277-281

1995

  1. Schizophrenia: Gender, family risk, and plasma homovanillic acid

    American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 60, Núm. 2, pp. 154-156

1994

  1. Homovanillic acid in plasma determined by HPLC with direct injection of plasma filtrates [9]

    Clinical Chemistry

1987

  1. Liquid-chromatographic method for determination of homovanillic acid in plasma, with electrochemical detection

    Clinical Chemistry, Vol. 33, Núm. 1, pp. 72-75

1984

  1. Adaptación dopaminérgica al tratamiento con neurolépticos: cambio de la correlación Dopamina vs DOPAC

    Psiquis: Revista de psiquiatría, psicología médica y psicosomática, Vol. 5, Núm. 1, pp. 29-32

  2. Excreción de 3,4-dimetoxifeniletilamina. Síntesis central y periférica.

    Archivos de Neurobiologia, Vol. 47, Núm. 1, pp. 19-28